Oscar Health, Inc. (OSCR Quick QuoteOSCR - Free Report) reported $2.99 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 23.2%. EPS of -$0.53 for the same period compares to -$0.22 a year ago.

The reported revenue represents a surprise of -3.37% over the Zacks Consensus Estimate of $3.09 billion. With the consensus EPS estimate being -$0.55, the EPS surprise was +3.64%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Oscar Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Membership by Offering - Individual and Small Group: 2.11 million compared to the 2.01 million average estimate based on two analysts.
• Medical loss ratio: 88.5% versus the two-analyst average estimate of 88.8%.
• Revenue- Investment income: $53.22 million compared to the $54.37 million average estimate based on two analysts.
• Revenue- Premium: $2.92 billion compared to the $3.03 billion average estimate based on two analysts.

View all Key Company Metrics for Oscar Health here>>>

Shares of Oscar Health have returned -21.9% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.